Previous enumeration of CTCs from NSCLC patients, using EpCAM-based immunomagnetic techniques, reported percentages of CTCs ranging between 6% and 20% using a cut-off ≥ 2 CTCs in 7.5 mL of blood. Here, EPCAM is linked to non-small cell lung carcinoma.